Does DARATUMUMAB Cause Therapeutic product effect incomplete? 215 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 215 reports of Therapeutic product effect incomplete have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.8% of all adverse event reports for DARATUMUMAB.
215
Reports of Therapeutic product effect incomplete with DARATUMUMAB
0.8%
of all DARATUMUMAB reports
25
Deaths
9
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From DARATUMUMAB?
Of the 215 reports, 25 (11.6%) resulted in death, 9 (4.2%) required hospitalization, and 6 (2.8%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARATUMUMAB. However, 215 reports have been filed with the FAERS database.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which DARATUMUMAB Alternatives Have Lower Therapeutic product effect incomplete Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE